Teleflex Incorporated (NYSE:TFX) Shares Sold by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. trimmed its position in Teleflex Incorporated (NYSE:TFX) by 7.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,313 shares of the medical technology company’s stock after selling 783 shares during the period. GHP Investment Advisors Inc.’s holdings in Teleflex were worth $1,835,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Simplify Asset Management Inc. purchased a new stake in shares of Teleflex in the third quarter valued at about $4,800,000. JPMorgan Chase & Co. lifted its position in Teleflex by 14.3% in the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after purchasing an additional 19,466 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in Teleflex by 19.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock valued at $102,000 after purchasing an additional 80 shares during the period. LGT Capital Partners LTD. boosted its holdings in Teleflex by 4.2% in the 3rd quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock valued at $57,300,000 after purchasing an additional 9,411 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its position in Teleflex by 41.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock worth $6,010,000 after purchasing an additional 7,132 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Trading Down 1.4 %

Shares of TFX stock opened at $173.61 on Friday. Teleflex Incorporated has a fifty-two week low of $171.69 and a fifty-two week high of $256.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The business has a fifty day simple moving average of $180.84 and a 200-day simple moving average of $211.88. The stock has a market cap of $8.06 billion, a P/E ratio of 34.51, a P/E/G ratio of 1.78 and a beta of 1.16.

Analyst Upgrades and Downgrades

Several analysts have recently commented on TFX shares. Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Truist Financial lowered their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Mizuho lowered their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, Teleflex currently has an average rating of “Moderate Buy” and an average target price of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.